Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

30.15 +0.65 (+2.20%)
Streaming Delayed Price Updated: 10:30 AM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,242,952
Open 29.42
Bid (Size) 30.15 (3)
Ask (Size) 30.16 (10)
Prev. Close 29.50
Today's Range 29.31 - 30.30
52wk Range 25.20 - 37.80
Shares Outstanding 5,606,688,356
Dividend Yield 5.44%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Under $50 Stocks to Buy Now: Q3 Edition
For small do-it-yourself investors looking for value, the following under $50 stocks are worth buying in July 2024. 
Via InvestorPlace
Forget Medical Properties Trust: This High-Yielding Dividend Stock Is a Much Better Buy
Medical Properties Trust's yield looks appealing, but it wouldn't have made up for the stock's 70% decline over the last three years. 
Via The Motley Fool

Performance

YTD
+1.41%
+1.41%
1 Month
+11.75%
+11.75%
3 Month
+17.36%
+17.36%
6 Month
+6.46%
+6.46%
1 Year
-15.92%
-15.92%

More News

Read More
7 High-Yield Dividend Stocks Beating Inflation
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Decoding Pfizer's Options Activity: What's the Big Picture?
Via Benzinga
Positive News is Driving This Cancer Drug Maker’s Stock Higher
Via MarketBeat
Why Pfizer Stock Is Moving Higher on Thursday
Via Benzinga
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
Via InvestorPlace
2 Pharma Stocks to Buy Hand Over Fist This Month
Via The Motley Fool
Inflation Drop Fuels Rate Cut Speculation, Investors Shift To Sector Laggards, Russell 2000 Surges Over 3.6%: This Week In The Markets
Via Benzinga
Topics Economy
Exposures Interest Rates
The Weight Loss Market Can Surge To $400B By 2032, And These Stocks Will Rule It
Via Talk Markets
With Oral Anti-Obesity Candidate Development, Pfizer Seeks Relevant And Competitive Presence - Goldman Sachs
Via Benzinga
Pfizer, L3Harris Technologies And More: CNBC's 'Final Trades'
Via Benzinga
Eli Lilly, Novo Nordisk Shares Dip As Pfizer Ramps Up Diabetes Drug Competition
Via Benzinga
Major Potential: 5 NASDAQ / NYSE Stocks Under $1 SGMO, FTCI, VTAK, SPRB, DNA
Via AB Newswire
Wall Street Weighs In As Pfizer Targets $100 Billion Weight Loss Market
Via Talk Markets
Pfizer Advances Once-Daily Weight-Loss Pill As It Catches Up To Tap The Lucrative Market
Via Benzinga
Pfizer Stock Jumps After Picking Daily Pill As Weight-Loss Drug
Via Investor's Business Daily
Premarket Stocks: 3 Fast Movers And 1 In A Buy Zone
Via Investor's Business Daily
7 High-Yield Dividend Stocks to Buy and Hold Forever: July Edition
Via InvestorPlace
3 High-Dividend Stocks to Buy if You Are Seeking Consistent Payouts
Via InvestorPlace
Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipron
From Pfizer Inc.
Via Business Wire
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
Via InvestorPlace
Pfizer And Mainz Provide Examples Of Using Emerging Technology For Good
Via Benzinga
S&P 500 2024 Q2 Earnings Preview: Aggregate Earnings Reaching A New High Watermark?
Via Talk Markets
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.